Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vascular endothelial growth factor receptor 2 gene (KDR) polymorphisms and expression levels in depressive disorder.

Journal of affective disorders - 1 May 2013

Gałecki Piotr, Orzechowska Agata, Berent Dominika, Talarowska Monika, Bobińska Kinga, Gałecka Elżbieta, Lewiński Andrzej, Maes Michael, Szemraj Janusz

Abstract excerpt

Recent research findings suggest that vascular endothelial growth factor (VEGF) participates in the development of depressive disorder. VEGF is involved in neurogenesis and neuroprotection processes, mediated by vascular endothelial growth factor receptor 2 (VEGFR2). VEGFR2 also plays a role in angiogenesis, a process related to neurogenesis and other biological processes. We examined VEGFR2 (KDR) gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Depressive Disorder
Share to KDR gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Polymorphism, Genetic

Share to Recurrence

Share to RNA, Messenger

Share to Vascular Endothelial Growth Factor Receptor-2

Source

Identifiers

PMID: 23164459
DOI: 10.1016/j.jad.2012.10.025

Genes

KDR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vascular endothelial growth factor receptor 2 gene (KDR) polymorphisms and expression levels in depressive disorder.PMID 23164459Read ↗

Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development.Semantic proximity Read ↗

Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder.Semantic proximity Read ↗

Depression and BMI influences the serum vascular endothelial growth factor level.Semantic proximity Read ↗

The Association of Biochemical and Genetic Biomarkers in VEGF Pathway with DepressionSemantic proximity Read ↗

VEGF-related polymorphisms identified by GWAS and risk for major depression.Semantic proximity Read ↗

Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response.Semantic proximity Read ↗

Circulating NEGR1 Protein Levels Associate with Symptom Severity in Drug-Naïve Major Depressive DisorderSemantic proximity Read ↗

Altered mRNA expressions for N-methyl-D-aspartate receptor-related genes in WBC of patients with major depressive disorderSemantic proximity Read ↗

Functional polymorphism of cyclooxygenase-2 gene (G-765C) in depressive patients.Semantic proximity Read ↗

An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder.Semantic proximity Read ↗

Reduced Vrk2 expression is associated with higher risk of depression in humans and mediates depressive-like behaviors in mice.Semantic proximity Read ↗

Cytokine- and Vascular Endothelial Growth Factor-Related Gene-Based Genome-Wide Association Study of Low-Dose Ketamine Infusion in Patients with Treatment-Resistant DepressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.